Expert Pitch

Rutgers Experts Available to Discuss Moderna Coronavirus Vaccine Rollout

Rutgers medical experts are available to discuss the FDA’s approval of Moderna’s coronavirus vaccine for emergency use and its rollout.

The Rutgers New Jersey Medical School is one of only two sites for the Phase 3 trial of the Moderna vaccine in New Jersey.

“This approval is an exciting step in expanding access to safe and effective vaccines to people who desperately need them and provides hope that the end of this pandemic is near,” said Shobha Swaminathan, an associate professor, principal investigator for the Moderna Phase 3 trial at Rutgers NJMS and medical director of the infectious disease practice at University Hospital.

“I, along with the rest of the health care community, am optimistic about the FDA’s emergency use authorization of the Moderna vaccine along with the ongoing distribution of the Pfizer-BioNTech vaccine, both of which have been shown to have high efficacy and safety,” said Brian Strom, chancellor of Rutgers Biomedical and Health Sciences and the executive vice president for Health Affairs at Rutgers University. “We enthusiastically celebrate this enormous advancement and urge people to accept the vaccine when it is their turn to get it. However, it is also critical to continue to be vigilant and patient. As states move forward with vaccine distribution, we must continue to observe recommended CDC and state and local public health guidelines, and to stay home if unwell or isolate if you have been around someone who has tested positive for the coronavirus.”

“It’s been a tremendous success to get another safe and effective vaccine available in the next vaccination process for vulnerable populations, and I urge the general public to take it when it becomes widely available to help save lives,” said Reynold Panettieri, a professor at the Rutgers Robert Wood Johnson Medical School and director of the Rutgers Institute for Translational Medicine and Science.

###

ABOUT RBHS

Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick, and collaborating university-wide, RBHS includes eight schools, a behavioral health network and four centers and institutes. RBHS offers an outstanding education in medicine, dentistry, pharmacy, public health, nursing, biomedical research and the full spectrum of allied health careers. RBHS clinical and academic facilities are located throughout the state.




Filters close

Showing results

110 of 5639
access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 10:00 AM EDT Released to reporters: 14-May-2021 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-May-2021 11:25 AM EDT
Access to overdose-reversing drugs declined during pandemic, researchers find
Beth Israel Lahey Health

In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.

Released: 14-May-2021 11:00 AM EDT
No Excuses: Stop Procrastinating on These Key Health Checks
Michigan Medicine - University of Michigan

A quick guide to the most-valuable preventive care that adults need to get scheduled, to catch up on what they may have missed during the height of the pandemic, and to address issues that the pandemic might have worsened.

Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:15 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.


Showing results

110 of 5639

close
1.221